Searched for
VAS NARASIMHAN NOVARTIS
Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- Why I have attended Davos for the last 20 years...Attending the World Economic Forum (WEF) in Davos has significantly shaped the writer's professional and personal growth. Originating with ...
- Novartis CEO 'very confident' on sales target, doesn't fear patent cliffNovartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday.
- Rs 17 crore for a single dose: Why Zolgensma is world's most expensive medicineThe high cost of Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy (SMA) in children under two, is to limited patien...
- When you are from different background and in different country, you are scrutinised more, says Novartis CEOAsserting that it's a really exciting moment to be in the world of medicine and R&D, Narasimhan said: "RNA therapeutics are opening up a wh...
- Novartis to spin off generics biz sandozThe company started a strategic review of Sandoz last October - examining a range of options, including retaining the business, spinning it...
- Novartis to slash up to 8,000 jobs globallyNovartis said in an emailed statement it had made good progress in implementing its new organisational structure that involved integrating ...
- Novartis CEO says it’ll take more than just vaccines to fight Covid pandemicEven once such a vaccine is on the market, Novartis AG Chief Executive Officer Vas Narasimhan said, it probably won’t protect everyone -- a...
- Novartis pays $678 million to resolve suit over sham doctor outingsThe settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on "speaking fe...
- COVID-19: Novartis to begin HCQ trialsEven as there is still question hanging over the efficacy of hydroxychloroquine (HCQ) as medication for Covid-19, Swiss drug maker Novartis...
- Novartis, U.S. regulators agree to malaria drug hydroxychloroquine trial against COVID-19Novartis has reached an agreement with U.S. regulators to hold a randomized trial of generic malaria drug hydroxychloroquine against COVID-...
- Novartis scraps sale of assets including COVID-19 hopeful to India's AurobindoNovartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulator...
- Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitungOther companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing i...
- ET Q&A: Need Government investments to develop cure for epidemics like Covid-19In the absence of sustained investments by government, the cure for epidemics such as Covid-19 becomes a challenge, Novartis global CEO Vas...
- Novartis to cut 2,200 jobs in Switzerland to boost profitabilityNovartis will cut about 2,200 jobs in Switzerland over the next four years as it consolidates production and shifts positions elsewhere to ...
- GSK may put iconic Horlicks for sale to fund $13-billion Novartis dealGSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.
- Three Indian-origin CEOs dine with Donald Trump in DavosVas Narasimhan from Novartis; Rajeev Suri from Nokia & Punit Renjen from Deloitte were part of the dinner that took place on the sidelines ...
- Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant NovartisHere’s everything that you need to know about the doctor-turned-CEO.
- Five Indians in Fortune's '40 under 40' list for this yearAs many as five Indians have featured in this year's Fortune 40 under 40 list, an annual ranking of the most influential young people in th...
Load More
